TAIWAN · TWSE / TPEx
Anbogen
安邦生技* · 7784 · Emerging Stock Board · Biotech and medical
Share price, 2026-10-19NT$10.401 month +11.9% · 1 year —
Directors and supervisors hold30,146,51016.1% of shares issued
Of which pledged0.0%0
Share price, last 12 months
Daily closes adjusted for cash and stock dividends, against the TAIEX index rebased to the same start. Prices from Yahoo Finance.
Directors, officers and major shareholders
Holdings reported for 2026-09. At election = shares held when the director was elected. Related parties = holdings of the person's spouse, minor children and nominees. One person with two roles is listed once.
| Person | Role | At election | Now | Of the company | Pledged | Related parties |
|---|---|---|---|---|---|---|
| 徐祖安 | Chairman · Other | 5,675,000 | 2,925,000 | 1.56% | — | 3,120,000 |
| 薛博仁 | Director · President | 8,000,000 | 8,300,000 | 4.42% | — | — |
| 中華開發貳生醫創業投資有限合夥 | Director | 13,444,444 | 14,689,289 | 7.83% | — | — |
| 孔德鈞 | Director (corporate representative) | — | 0 | — | — | — |
| 網盈國際有限合夥 | Director | 4,166,666 | 4,166,666 | 2.22% | — | — |
| 郭秀娟 | Director (corporate representative) | — | 0 | — | — | — |
| 羅麗珠 | Independent director | 60,000 | 65,555 | 0.03% | — | — |
| 鄭鈞元 | Independent director | — | 0 | — | — | — |
| 郭仲乾 | Independent director | — | 0 | — | — | — |
| 楊弘毅 | Vice president | — | 155,000 | 0.08% | — | — |
| 吳崇楷 | Vice president | — | 1,007,066 | 0.54% | — | — |
| 王相立 | Vice president | — | 200,000 | 0.11% | — | 125,000 |
| 謝志逸 | Vice president | — | 500,000 | 0.27% | — | — |
| 張智為 | Vice president | — | 0 | — | — | — |
| 楊菁菁 | Assistant vice president | — | 300,000 | 0.16% | — | — |
| 何怜儀 | Chief financial officer | — | 23,000 | 0.01% | — | — |
| 賴淑蓉 | Chief accountant | — | 125,000 | 0.07% | — | 200,000 |
| 黃子庭 | Other | — | 38,000 | 0.02% | — | — |
| 洪旭昇 | Other | — | 300,000 | 0.16% | — | — |